221 related articles for article (PubMed ID: 24209900)
1. Ifosfamide related encephalopathy: the need for a timely EEG evaluation.
Feyissa AM; Tummala S
J Neurol Sci; 2014 Jan; 336(1-2):109-12. PubMed ID: 24209900
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide encephalopathy and nonconvulsive status epilepticus.
Primavera A; Audenino D; Cocito L
Can J Neurol Sci; 2002 May; 29(2):180-3. PubMed ID: 12035842
[TBL] [Abstract][Full Text] [Related]
3. Clinical and EEG Characteristics of Ifosfamide-Related Encephalopathy.
Gusdon AM; Malani R; Chen X
J Clin Neurophysiol; 2019 Mar; 36(2):150-154. PubMed ID: 30694943
[TBL] [Abstract][Full Text] [Related]
4. [Ifosfamide induced encephalopathy: 15 observations].
Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
[TBL] [Abstract][Full Text] [Related]
5. Nonconvulsive status epilepticus due to ifosfamide.
Kilickap S; Cakar M; Onal IK; Tufan A; Akoglu H; Aksoy S; Erman M; Tekuzman G
Ann Pharmacother; 2006 Feb; 40(2):332-5. PubMed ID: 16449538
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.
Cherry MA; Bhardwaj H; Hopps S; Srour S; Pant S
J Oncol Pharm Pract; 2013 Sep; 19(3):261-4. PubMed ID: 23135805
[TBL] [Abstract][Full Text] [Related]
7. An assessment of risk factors associated with ifosfamide-induced encephalopathy in a large academic cancer center.
Szabatura AH; Cirrone F; Harris C; McDonnell AM; Feng Y; Voit D; Neuberg D; Butrynski J; Fisher DC
J Oncol Pharm Pract; 2015 Jun; 21(3):188-93. PubMed ID: 24664476
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide chemotherapy and nonconvulsive status epilepticus: case report and review of the literature.
Taupin D; Racela R; Friedman D
Clin EEG Neurosci; 2014 Jul; 45(3):222-5. PubMed ID: 24151171
[TBL] [Abstract][Full Text] [Related]
9. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
Pelgrims J; De Vos F; Van den Brande J; Schrijvers D; Prové A; Vermorken JB
Br J Cancer; 2000 Jan; 82(2):291-4. PubMed ID: 10646879
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: A retrospective analysis.
Lo Y; Shen LJ; Chen WH; Dong YH; Wu FL
J Formos Med Assoc; 2016 Sep; 115(9):744-51. PubMed ID: 26302952
[TBL] [Abstract][Full Text] [Related]
11. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL
Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837
[TBL] [Abstract][Full Text] [Related]
12. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
Sweiss KI; Beri R; Shord SS
Drug Saf; 2008; 31(11):989-96. PubMed ID: 18840018
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide induced encephalopathy following chemotherapy of Non-Hodgkin's Lymphoma.
Jain S; Moger V; Kumari S; Varma S
Neurol India; 2001 Dec; 49(4):416. PubMed ID: 11799423
[No Abstract] [Full Text] [Related]
14. The Use of Continuous Veno-Venous Hemodiafiltration in the Management of Ifosfamide-induced Encephalopathy: A Case Report.
Yeo KK; HaDuong JH
J Pediatr Hematol Oncol; 2016 Aug; 38(6):489-90. PubMed ID: 26907647
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide-induced encephalopathy due to a novel formulation of ifosfamide.
Filhon B; Lacarra B; Hervouet C; Jaffray M; Schneider P; Vannier JP
Pediatr Blood Cancer; 2016 Feb; 63(2):372-3. PubMed ID: 26397980
[No Abstract] [Full Text] [Related]
16. Response Rates to Anticonvulsant Trials in Patients with Triphasic-Wave EEG Patterns of Uncertain Significance.
O'Rourke D; Chen PM; Gaspard N; Foreman B; McClain L; Karakis I; Mahulikar A; Westover MB
Neurocrit Care; 2016 Apr; 24(2):233-9. PubMed ID: 26013921
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide encephalopathy associated with chemotherapy for musculoskeletal sarcomas: incidence, severity, and risk factors.
Tajino T; Kikuchi S; Yamada H; Takeda A; Konno S
J Orthop Sci; 2010 Jan; 15(1):104-11. PubMed ID: 20151259
[TBL] [Abstract][Full Text] [Related]
18. Emergent EEG is helpful in neurology critical care practice.
Firosh Khan S; Ashalatha R; Thomas SV; Sarma PS
Clin Neurophysiol; 2005 Oct; 116(10):2454-9. PubMed ID: 16122983
[TBL] [Abstract][Full Text] [Related]
19. Evaluating risk factors for the development of ifosfamide encephalopathy.
David KA; Picus J
Am J Clin Oncol; 2005 Jun; 28(3):277-80. PubMed ID: 15923801
[TBL] [Abstract][Full Text] [Related]
20. Treatment of ifosfamide encephalopathy with intravenous thiamin.
Buesa JM; García-Teijido P; Losa R; Fra J
Clin Cancer Res; 2003 Oct; 9(12):4636-7. PubMed ID: 14555540
[No Abstract] [Full Text] [Related]
[Next] [New Search]